What is Edwards Lifesciences's investments - amortized cost basis?

Edwards Lifesciences (EW) reported investments - amortized cost basis of $1.23B in Q1 2026.

How has Edwards Lifesciences's investments - amortized cost basis changed year-over-year?

Edwards Lifesciences's investments - amortized cost basis increased by 48.9% year-over-year, from $827.80M to $1.23B.

What is the long-term trend for Edwards Lifesciences's investments - amortized cost basis?

Over 5 years (2020 to 2025), Edwards Lifesciences's investments - amortized cost basis has grown at a 7.1% compound annual growth rate (CAGR), from $924.30M to $1.30B.

Non-Current Assets

Investments - Amortized Cost Basis

Edwards Lifesciences Investments - Amortized Cost Basis decreased by 5.3% to $1.23B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 48.9%, from $827.80M to $1.23B. Over 5 years (FY 2020 to FY 2025), Investments - Amortized Cost Basis shows an upward trend with a 7.1% CAGR.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

First reportedQ4 2015

Last reportedQ1 2026May 6, 2026

Metric ID: investments_amortized_cost

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$1.14B	$1.40B	$2.19B	$1.89B	$1.71B	$1.72B	$1.55B	$1.36B	$1.23B	$1.06B	$87.60M	$767.70M	$534.30M	$104.90M	$1.03B	$827.80M	$839.40M	$1.18B	$1.30B	$1.23B
QoQ Change	—	+22.9%	+56.5%	-13.9%	-9.4%	+0.4%	-9.8%	-11.9%	-9.6%	-14.1%	-91.7%	+776.4%	-30.4%	-80.4%	+878.5%	-19.3%	+1.4%	+40.4%	+10.5%	-5.3%
YoY Change	—	—	—	—	+50.1%	+22.7%	-29.4%	-27.7%	-27.9%	-38.3%	-94.3%	-43.7%	-56.7%	-90.1%	>999%	+7.8%	+57.1%	>999%	+26.8%	+48.9%

Range$87.60M – $2.19B

CAGR+1.7%

Avg YoY Growth+118.8%

Median YoY Growth-10.0%

Investments - Amortized Cost Basis at Other Companies

Boston ScientificBSX View metric

MedtronicMDT View metric

Frequently Asked Questions

What is Edwards Lifesciences's investments - amortized cost basis?: Edwards Lifesciences (EW) reported investments - amortized cost basis of $1.23B in Q1 2026.
How has Edwards Lifesciences's investments - amortized cost basis changed year-over-year?: Edwards Lifesciences's investments - amortized cost basis increased by 48.9% year-over-year, from $827.80M to $1.23B.
What is the long-term trend for Edwards Lifesciences's investments - amortized cost basis?: Over 5 years (2020 to 2025), Edwards Lifesciences's investments - amortized cost basis has grown at a 7.1% compound annual growth rate (CAGR), from $924.30M to $1.30B.